3-52392868-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_015512.5(DNAH1):c.10317C>T(p.Ile3439Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0446 in 1,608,620 control chromosomes in the GnomAD database, including 1,787 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 141 hom., cov: 30)
Exomes 𝑓: 0.045 ( 1646 hom. )
Consequence
DNAH1
NM_015512.5 synonymous
NM_015512.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.67
Publications
12 publications found
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
- spermatogenic failure 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- ciliary dyskinesia, primary, 37Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic male infertility due to sperm motility disorderInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 3-52392868-C-T is Benign according to our data. Variant chr3-52392868-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 478382.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0381 (5666/148804) while in subpopulation NFE AF = 0.0494 (3323/67324). AF 95% confidence interval is 0.048. There are 141 homozygotes in GnomAd4. There are 2595 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 141 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAH1 | NM_015512.5 | c.10317C>T | p.Ile3439Ile | synonymous_variant | Exon 65 of 78 | ENST00000420323.7 | NP_056327.4 | |
| DNAH1 | XM_017006129.2 | c.10386C>T | p.Ile3462Ile | synonymous_variant | Exon 67 of 80 | XP_016861618.1 | ||
| DNAH1 | XM_017006130.2 | c.10317C>T | p.Ile3439Ile | synonymous_variant | Exon 66 of 79 | XP_016861619.1 | ||
| DNAH1 | XM_017006131.2 | c.10260C>T | p.Ile3420Ile | synonymous_variant | Exon 66 of 79 | XP_016861620.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH1 | ENST00000420323.7 | c.10317C>T | p.Ile3439Ile | synonymous_variant | Exon 65 of 78 | 1 | NM_015512.5 | ENSP00000401514.2 | ||
| DNAH1 | ENST00000486752.5 | n.10774C>T | non_coding_transcript_exon_variant | Exon 64 of 77 | 2 | |||||
| DNAH1 | ENST00000488988.5 | n.2103C>T | non_coding_transcript_exon_variant | Exon 12 of 25 | 2 | |||||
| DNAH1 | ENST00000490713.5 | n.1017C>T | non_coding_transcript_exon_variant | Exon 8 of 20 | 5 | ENSP00000419071.1 |
Frequencies
GnomAD3 genomes AF: 0.0381 AC: 5665AN: 148688Hom.: 140 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
5665
AN:
148688
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0373 AC: 9259AN: 248252 AF XY: 0.0375 show subpopulations
GnomAD2 exomes
AF:
AC:
9259
AN:
248252
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0453 AC: 66152AN: 1459816Hom.: 1646 Cov.: 40 AF XY: 0.0449 AC XY: 32611AN XY: 726106 show subpopulations
GnomAD4 exome
AF:
AC:
66152
AN:
1459816
Hom.:
Cov.:
40
AF XY:
AC XY:
32611
AN XY:
726106
show subpopulations
African (AFR)
AF:
AC:
768
AN:
33438
American (AMR)
AF:
AC:
1648
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
AC:
784
AN:
26102
East Asian (EAS)
AF:
AC:
660
AN:
39542
South Asian (SAS)
AF:
AC:
1709
AN:
86234
European-Finnish (FIN)
AF:
AC:
1775
AN:
53194
Middle Eastern (MID)
AF:
AC:
210
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
55791
AN:
1110608
Other (OTH)
AF:
AC:
2807
AN:
60262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3408
6815
10223
13630
17038
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2042
4084
6126
8168
10210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0381 AC: 5666AN: 148804Hom.: 141 Cov.: 30 AF XY: 0.0359 AC XY: 2595AN XY: 72374 show subpopulations
GnomAD4 genome
AF:
AC:
5666
AN:
148804
Hom.:
Cov.:
30
AF XY:
AC XY:
2595
AN XY:
72374
show subpopulations
African (AFR)
AF:
AC:
827
AN:
40292
American (AMR)
AF:
AC:
721
AN:
14818
Ashkenazi Jewish (ASJ)
AF:
AC:
103
AN:
3452
East Asian (EAS)
AF:
AC:
102
AN:
4994
South Asian (SAS)
AF:
AC:
99
AN:
4632
European-Finnish (FIN)
AF:
AC:
311
AN:
10046
Middle Eastern (MID)
AF:
AC:
12
AN:
290
European-Non Finnish (NFE)
AF:
AC:
3323
AN:
67324
Other (OTH)
AF:
AC:
93
AN:
2060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
267
534
800
1067
1334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
123
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.